Bingham Osborn & Scarborough’s Thermo Fisher Scientific TMO Stock Holding History

Bingham Osborn & Scarborough’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,064	Closed	-$608K	–	125
2021 Q3	$608K	Buy	1,064 +76	+8%	+$41.7K	0.04%	72
2021 Q2	$498K	Buy	988 +96	+11%	+$45.3K	0.04%	91
2021 Q1	$407K	Sell	892 -30	-3%	-$14.3K	0.03%	95
2020 Q4	$429K	Buy	922 +105	+13%	+$49.2K	0.03%	76
2020 Q3	$361K	Sell	817 -4	-0.5%	-$1.65K	0.03%	113
2020 Q2	$297K	Sell	821 -6	-0.7%	-$2.01K	0.02%	120
2020 Q1	$235K	Buy	827 +1	+0.1%	+$315	0.02%	128
2019 Q4	$268K	Buy	826 +21	+3%	+$6.37K	0.02%	133
2019 Q3	$234K	Buy	+805	New	+$231K	0.02%	135

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bingham Osborn & Scarborough's TMO Position: Q4 2021 in Review

Bingham Osborn & Scarborough sold out of Thermo Fisher Scientific (TMO) in Q4 2021, closing a stake of 1,064 shares — an estimated $608K sold.

Bingham Osborn & Scarborough first reported a position in TMO in Q3 2019 and held it in 9 quarters. The position peaked at $608K in Q3 2021. 2,342 funds tracked by Wall St. Rank hold TMO as of Q4 2021.

Bingham Osborn & Scarborough reported no remaining Thermo Fisher Scientific position as of Q4 2021 after selling out during the quarter.
Bingham Osborn & Scarborough sold 1,064 Thermo Fisher Scientific shares in Q4 2021, an estimated $608K.
Bingham Osborn & Scarborough first reported a position in Thermo Fisher Scientific in Q3 2019 and held it in 9 quarters.
Bingham Osborn & Scarborough's Thermo Fisher Scientific position peaked at $608K in Q3 2021.
2,342 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2021.

Based on Bingham Osborn & Scarborough's 13F filing for Q4 2021.